The team at Acorn Regulatory has been busy all year working with our global client base. Nevertheless, they have taken… Read more
In the latest Acorn Regulatory careers blog our CMO Brian Cleary writes and speaks about the importance of STEM careers… Read more
In Acorn Regulatory News for December 2016 we are looking back at five of the stories over the past month that… Read more
We’re looking at the 5 most read medical device news stories from AcornRegulatory.com for the past 12 months. What a… Read more
Acorn Regulatory welcomed representatives from eleven Chinese pharmaceutical companies today at our Clonmel headquarters.
The WDA process is complex. Indeed, many companies turn to us to manage the application process on their behalf.
The EMA guidelines on first in human clinical trials have been revised. The European Medicines Agency issued its proposed revisions… Read more
Right now we have a Regulatory Affairs Consultant vacancy in our pharmaceutical team and we are interested in speaking to candidates… Read more
In an extract from our second Brexit whitepaper, we look at the impact of Brexit on regulatory affairs and issues… Read more
The UK pharmaceutical sector employs in excess of seventy thousand people. The structure of a Brexit will have significant impact… Read more
This month in our news roundup we are looking at Wholesale Distribution Authorisation (WDA), President-Elect Trump, awards and more.
For those of us working in the sector, the future location of the European Medicines Agency has been a consistent… Read more
